Venous Thromboembolism and Bleeding after Transurethral Resection of the Prostate (TURP) in Patients with Preoperative Antithrombotic Therapy: A Single-Center Study from a Tertiary Hospital in China.
Zhongyi LiZhihuan ZhengXuesong LiuQuan ZhuKaixuan LiLi HuangZhao WangZheng-Yan TangPublished in: Journal of clinical medicine (2023)
Short-term preoperative discontinuation may help patients with antithrombotic therapy to obtain a relatively safe opportunity for TURP surgery after professional evaluation of perioperative conditions. The risks of perioperative bleeding, VTE, and serious cardiovascular and cerebrovascular complications are relatively controllable. It is essential for urologists to pay more attention to the perioperative management of these patients. However, further high-quality research results are needed for more powerful verification.
Keyphrases
- venous thromboembolism
- patients undergoing
- atrial fibrillation
- cardiac surgery
- end stage renal disease
- prostate cancer
- direct oral anticoagulants
- newly diagnosed
- minimally invasive
- chronic kidney disease
- benign prostatic hyperplasia
- peritoneal dialysis
- risk factors
- prognostic factors
- acute kidney injury
- acute coronary syndrome
- coronary artery bypass
- cell therapy
- patient reported outcomes
- patient reported